Skip to main content
TipRanks
Go Ultimate75% OFF

Huakang Biomedical Holdings Company Limited (8622) Income Statement

0 Followers

Huakang Biomedical Holdings Company Limited Income Statement

Last quarter (Q2 2026), Huakang Biomedical Holdings Company Limited's total revenue was ¥8.28M, an increase of 34.29% from the same quarter last year. In Q2, Huakang Biomedical Holdings Company Limited's net income was ¥-1.21M. See Huakang Biomedical Holdings Company Limited’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
¥ 28.28M¥ 25.36M¥ 24.63M¥ 25.33M¥ 26.13M
¥ 17.77M¥ 17.07M¥ 16.09M¥ 16.91M¥ 16.46M
¥ 26.34M¥ 22.08M¥ 23.48M¥ 22.00M¥ 21.03M
Depreciation and Amortization¥ 3.72M¥ 3.33M¥ 3.18M¥ 3.14M¥ 2.95M
¥ -4.17M¥ -1.68M¥ -2.55M¥ 188.00K¥ -852.00K
¥ -7.81M¥ -5.69M¥ -7.39M¥ -5.09M¥ -4.33M
¥ 2.80M¥ 1.53M¥ 1.61M¥ 2.08M¥ 675.00K
¥ -5.01M¥ -4.16M¥ -5.78M¥ -3.01M¥ -3.90M
¥ -5.01M¥ -4.16M¥ -5.78M¥ -3.08M¥ -4.22M
Per Share Metrics
Basic EPS¥ -0.01¥ -0.01¥ -0.01¥ -0.01¥ -0.01
Diluted EPS¥ -0.01¥ -0.01¥ -0.01¥ -0.01¥ -0.01
Weighted Average Shares Outstanding501.44M482.44M415.96M404.64M400.00M
Weighted Average Shares Outstanding (Diluted)501.44M482.44M415.96M404.64M400.00M

Currency in CNY

Huakang Biomedical Holdings Company Limited Earnings and Revenue History

-20M020M40M-60 %-40 %-20 %0 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin